Who is sponsoring NCT01890538?

NCT01890538 is sponsored by Kocaeli University.

What condition does NCT01890538 study?

NCT01890538 studies Peripheral Vertigo.

What drugs are being tested in NCT01890538?

Interventions: Administration of 100 mg dimenhydrinate intravenous, 2 g piracetam intravenous.

What is the status of NCT01890538?

NCT01890538 is currently COMPLETED.

Last reviewed 2014-05-02 · How we verify

Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial

NCT01890538 Phase 4 COMPLETED

This study aims to investigate efficacy of two different intravenous drugs (dimenhydrinate and piracetam) in the symptomatic management of peripheral vertigo. The patients will be randomized in two groups according to symptomatic treatment modalities: Dimenhydrinate (100 mg) and piracetam (2 g) will be given in 100 cc normal saline in 30 minutes. Each patient will be asked if her/his vertigo symptoms resolved or not, according to a numeric rating scale (0=no vertigo, 10=worst possible vertigo). The patient will be rate the intensity of symptoms in the following times: * Numeric rating scale (1 to 10): Admission * Numeric rating scale (1 to 10): After the study drug (No ambulation)\* * Numeric rating scale (1 to 10): After the study drug (Ambulation)\* * Ambulation refers to head movements or walking in the room, if applicable.

Details

Lead sponsor	Kocaeli University
Phase	Phase 4
Status	COMPLETED
Enrolment	94
Start date	2013-06
Completion	2014-05

Conditions

Peripheral Vertigo

Interventions

Administration of 100 mg dimenhydrinate intravenous
2 g piracetam intravenous

Primary outcomes

Change in numeric rating scale — Change from baseline in numeric rating scale at 30th minute

Countries

Turkey (Türkiye)